Men's health clinic marketing
Sell the visit, not the prescription. Men's health marketing meets prescription and controlled-substance ad rules before it meets a patient, and a national telehealth brand has often shown him a monthly price first. So the ads sell what the clinic does first, the consult and the lab draw, and the prescription stays with the clinician who reads his results.
Book a 30-minute callFill The Lobby is a men's health marketing agency for men's health, TRT and hormone clinics of every size in the US, from a solo clinician to a large group practice. Two rules shape this specialty before anything else. Testosterone is a Schedule III controlled substance (21 CFR 1308.13, annual edition revised as of 1 April 2025, checked 3 November 2026), and Google requires certification to serve ads for prescription drug services, with telemedicine providers named among them (Google Ads policy, checked 3 November 2026). Fill The Lobby settles which ad category each of your services falls into in week one, writes campaigns to those rules, and runs them inside the clinic’s own ad accounts, where the ad spend goes directly to Google and Meta. Work starts with a 30-day Proof Pilot at one flat fee of $2,500. After the pilot, plans are priced per practice by clinician count.
What actually books a men's health consult.
Advertise the consult and the labs, not the drug
Federal regulations list testosterone, including its salts, esters and ethers, among the anabolic steroids in Schedule III (21 CFR 1308.13(f), annual edition revised as of 1 April 2025, checked 3 November 2026). An ad that reads like a quicker route to a controlled substance is the wrong ad, and it pulls in the man your clinician would turn away at the consult. So TRT marketing sells what the clinic does first: a consultation, a lab draw and a clinician who goes through the results with him. Whether anything is prescribed is decided in the room, by the person licensed to decide it.
Prescribing online changes who approves the ads
Google’s United States rules allow telemedicine providers that hold LegitScript’s Healthcare Merchant Certification, and add that the advertiser must also be certified with Google (Google Ads policy, checked 3 November 2026). LegitScript runs that program for pharmacies, telehealth providers and other healthcare companies, and lists remote clinical care that includes diagnosis, treatment and prescribing as a reason a telemedicine provider may qualify (LegitScript, checked 3 November 2026). On Meta, online pharmacies and telehealth providers need active LegitScript certification and then Meta’s own authorization to run prescription drug ads, and those ads can target only people 18 or older in the US, Canada or New Zealand (Meta advertising standards, checked 3 November 2026). A clinic that sees every patient in person and a clinic that prescribes by video are two different advertisers under these rules, and one clinic can be both at once. Certification is LegitScript’s decision, and ad approval is Google’s and Meta’s.
ED ads go to adults and stay on health
On Google, prescription drugs for erectile dysfunction may be promoted only by pharmaceutical manufacturers, online pharmacies and telemedicine providers, only in the US, Canada and New Zealand, only after they apply to Google, only to users 18 or older, and never in a way that focuses on sexual pleasure or enhancement (Google Ads policy, checked 3 November 2026). A clinic that treats ED in person advertises the visit instead: a medical problem, looked at by a clinician, explained in plain words. No innuendo and no performance promises. The ad reads like a clinic, because it is one.
Privacy decides the booking
A man looking into low testosterone or ED is often weighing who else will see the email, the text and the voicemail before he books anything. The ad platforms draw a line here too. Google counts physical health conditions and sexual health as health content in personalized advertising, which rules out Customer Match and your data segments, so these campaigns can’t be aimed at your patient list or follow your past site visitors, and reach comes from the searches men type and the area you serve (Google Ads policy, checked 3 November 2026). That puts the weight on the first booking. The form asks only what booking needs, the confirmation names the clinic and the time and nothing about the treatment, and every follow-up goes to the channel he picked.
National telehealth sets the price he expects
Plenty of men arrive having seen a national brand quote a monthly price in their feed, so the first question is what you cost. Your page answers it before he has to ask: what the first visit and the labs cost, and what the membership charges each month. Google asks for the same thing. Its pricing rule, enforced since 28 October 2025, says advertisers “must clearly and conspicuously disclose the payment model or full expense that a user will bear before and after purchase”, and its examples include “promoting a free trial without clearly stating the trial period” or that the user will be charged automatically when it ends (Google Ads policy, checked 3 November 2026). So a membership offer says it bills monthly and what each month costs, and a free first month says when the charges start. Then the page shows what that monthly price covers at your clinic: which labs, how often they are rechecked, and the clinician who reads them.
Labs first. The clinician decides the rest.
Consults, lab draws, membership starts and cost per new member, visible weekly. BAA signed before any data moves.
The only agency that is also the customer.
We built and run our own clinical platforms (200+ clinicians, patients in 20+ countries), and every part of this system, from the ads to the answered call and the follow-up, runs there first, on our own money. Fill The Lobby is that engine, pointed at your practice.
We do this in other specialties too.
The lab draw that never gets booked
He asks about getting his levels checked late on a Sunday. Your front desk calls back on Monday afternoon from a number he doesn’t know, while he is at work, and he lets it ring. When someone does reach him, the consult gets booked and the lab draw becomes his job: a separate call, the prep your clinicians ask for, and a slot he would have to take time off work for. He says he will call back to book it. By then a national brand has emailed him a monthly price twice, and the draw goes back on the list of things he will do eventually.
So the lab slot goes in the first reply, while he is still holding the phone, by text if that is what he chose, with the prep your clinicians ask for and the price of the visit and the labs. The draw is booked first, because the results visit has nothing to discuss without it. If he books and doesn’t show, a new slot reaches him that day, with no reprimand attached. Each week you see every inquiry, how fast it was answered and which ones reached a lab draw.
The membership that lapses after the first refill
The first month looks fine on paper: labs, a results visit, a plan, the first prescription filled. Then the recheck your clinicians want comes due, and nobody books it. The second monthly charge arrives before he has seen anyone again, and with no visit in between it reads like a subscription he forgot to cancel. One declined card later the membership is gone, and the clinic finds out at month-end, if anyone looks.
We run the follow-up on the recheck schedule your clinicians set, not a marketing calendar. The recheck goes on the calendar before he leaves the results visit, the reminder names the appointment and not the treatment, and a skipped recheck reaches your front desk that day as a name to call, not as a third automated text. The weekly report lists every member by recheck date, with the ones who missed it at the top, while there is still a visit on the calendar to save.
Where the rest of it leaks
In testosterone clinic marketing nothing is judged on clicks: the paid ads for medical practices we run are counted on lab draws and membership starts, because a TRT campaign can fill an inbox with men who only wanted the price. The booking flow lives on booking pages that put a lab slot on your real calendar in the first step, and missed call recovery rings back the calls that land while your staff are drawing blood. Reminders before each recheck and the reply to a skipped visit are patient follow-up. Winning back members who cancelled months ago is patient reactivation, part of the higher-tier plans that follow the pilot. The full eight, and how they hand off to each other, are laid out under what we do. Retention here is members staying on the plan their clinician set, and the patient retention calculator separates members who stopped before their clinician said they were done from the ones still on the plan, and puts a yearly figure on missed rechecks. All of it maps onto the seven leaks we look for in week one.
Hormone replacement therapy marketing.
Plenty of hormone clinics treat women too, seeing men for testosterone and women for menopause care under one roof, and one rule covers both sides of hormone clinic marketing. Google’s non-exhaustive list of prescription drugs includes brand-name hormone products such as AndroGel, Depo-Testosterone, Testim, Estrace and Estraderm (Google’s prescription drug list, checked 3 November 2026). Google lets US advertisers use those names in ad text and on landing pages without certification, and keeps keyword targeting on them for certified advertisers (restricted drug terms policy, checked 3 November 2026). So hormone therapy marketing builds its keywords on the care people search for: a menopause consult, hormone testing, a clinic near them.
BHRT marketing carries a claims risk of its own. Words like “bioidentical” and “natural” invite comparisons about safety that belong in the consult, not in an ad. So the copy describes the visit, the testing and who prescribes, and leaves the choice of hormone to the clinician and the patient in the room.
Questions
Men's health marketing: what clinic owners ask.
Updated November 2026.